Amerikanische Gesellschaft für Hirudotherapie

Efficacy of leech therapy in the management of osteoarthritis (Sandhivata)

Rai PK, Singh AK, Singh OP, Rai NP, Dwivedi AK (2011) · Ayu · n=25

RCT evidence detailTrial reference
GRADE Very LowInsufficient evidenceCondition: Knee Osteoarthritis
Sample size of this trial compared with other Knee Osteoarthritis trialsWang H 2018264Lauche R 2025240Lauche R 2014237Farzali S 2025181Cui Y 2024144Andereya S 2008113Andereya S 2008113Sarbaev IS 201996Isik M 201790Rai PK 201125
This trial (highlighted) by sample size alongside other indexed Knee Osteoarthritis trials. Larger trials generally carry more statistical weight.

Study Profile

Design
single-center, open-label clinical trial within the Ayurvedic Jalaukavacharana (leech therapy) framework (Institute of Medical Sciences, Banaras Hindu University, Varanasi, India)
Sample size (n)
25
Intervention
Jalaukavacharana (Ayurvedic leech therapy with Hirudo medicinalis) applied to painful periarticular sites of the affected joint over multiple sessions
Comparator
Within-subject pre/post comparison without a randomized control arm (descriptive efficacy assessment)
Primary endpoint
Symptomatic improvement in pain and joint mobility in patients with osteoarthritis (Sandhivata, a Vatavyadhi condition in Ayurvedic classification)
Primary result
Encouraging clinical improvements reported in pain and mobility following leech therapy in osteoarthritis patients (descriptive, no inferential statistics on between-group comparison)
Follow-up duration
follow-up over the treatment course (specific weeks not standardized)

Key Findings

  • First Indian Ayurvedic clinical evaluation of Jalaukavacharana for osteoarthritis (Sandhivata) indexed in PubMed
  • Positions leech therapy within the Raktamokshan (bloodletting) parasurgical paradigm of Ayurveda
  • Attributes mechanism to anti-inflammatory and anaesthetic substances in leech saliva consistent with modern biochemistry
  • Cited as supportive evidence for use of leech therapy in degenerative joint disease as a low-side-effect alternative to NSAIDs
  • Reported as encouraging by authors; no inferential between-group statistical tests provided due to within-subject design

Limitations

  • Not a randomized controlled trial - within-subject descriptive evaluation only
  • No defined control comparator arm; pre/post within-subject design only
  • Small sample (typical Ayurvedic clinical evaluation cohort)
  • Outcome measures not standardized to WOMAC, VAS, or other validated OA instruments
  • Single Ayurvedic teaching institution - generalizability to broader OA populations limited

Clinical Implications

Rai 2011 is the most-cited Indian Ayurvedic clinical evaluation of Jalaukavacharana for osteoarthritis, providing methodological context for understanding leech therapy as practiced in the Ayurvedic regimental therapy tradition rather than as a standalone intervention. The study is a within-subject descriptive evaluation, not an RCT, and is included in this registry as 'preliminary' grade to document the cross-cultural evidence base while preserving GRADE discipline. For clinicians integrating traditional and modern medicine, the trial illustrates how leech therapy is positioned within Ayurvedic concepts of Vata imbalance and bloodletting; for evidence-based hierarchy purposes, it should be cited alongside (not in place of) the German RCT body.

Related Trials

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.